Article
Metastatic squamous cell non-small-cell lung cancer (NSCLC): disrupting the drug treatment…
Drugs in context · 2015 · SL. Scarpace
Key facts
| Title | Metastatic squamous cell non-small-cell lung cancer (NSCLC): disrupting the drug treatment paradigm with immunotherapies. |
|---|---|
| First author | SL. Scarpace |
| Journal | Drugs in context |
| Published | Oct 14, 2015 |
| DOI | 10.7573/dic.212289 |
| PubMed ID | 26576187 |
| PMC ID | PMC4630973 |
| Devices mentioned | 212289 |
At a glance
- 1–9 FDA submissions mentioned
- None Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1